Carlos Henrique Camargo

Dr. Carlos Henrique Camargo

Instituto Adolfo Lutz, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
ABAriane Bruder-Nascimento
Ariane Bruder-Nascimento
Carlos Henrique CamargoCarlos Henrique Camargo
Carlos Henrique Camargo
MSMaria F Sugizaki
Maria F Sugizaki
TSTerue Sadatsune
Terue Sadatsune
AMAugusto C Montelli
Augusto C Montelli
EBEduardo Bagagli
Eduardo Bagagli
Species identification and antifungal susceptibility tests were carried out on 212 Candida isolates obtained from bloodstream infections, urinary tract infections and dialysis-associated peritonitis, from cases attended at a Brazilian public tertiary hospital from January 1998 to January 2005.

5 December 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
Danilo Yamamoto ThomazDanilo Yamamoto Thomaz
Danilo Yamamoto Thomaz
JAJoão Nobrega de Almeida
João Nobrega de Almeida
GLGlaucia Moreira Espindola Lima
Glaucia Moreira Espindola Lima
MNMaína de Oliveira Nunes
Maína de Oliveira Nunes
Carlos Henrique CamargoCarlos Henrique Camargo
Carlos Henrique Camargo
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
The incidence of candidemia by the Candida parapsilosis complex has increased considerably in recent decades, frequently related to use of indwelling intravascular catheters. The ability of this pathogen to colonize healthcare workers (HCW)' hands, and to form biofilm on medical devices has been associated with the occurrence of nosocomial outbreaks and high mortality rates. Fluconazole has been the leading antifungal drug for the treatment of invasive candidiasis in developing countries. However, azole-resistant C. parapsilosis isolates are emerging worldwide, including in Brazil. Few studies have correlated outbreak infections due to C. parapsilosis with virulence factors, such as biofilm production. We thus conducted a microbiological investigation of C. parapsilosis complex isolates from a Brazilian teaching hospital. Additionally, we identified a previously unrecognized outbreak caused by a persistent azole-resistant C. parapsilosis (sensu stricto) clone in the intensive care unit (ICU), correlating it with the main clinical data from the patients with invasive candidiasis. The molecular identification of the isolates was carried out by PCR-RFLP assay; antifungal susceptibility and biofilm formation were also evaluated. The genotyping of all C. parapsilosis (sensu stricto) was performed by microsatellite analysis and the presence of ERG11 mutations was assessed in the azole non-susceptible isolates. Fourteen C. parapsilosis (sensu stricto) isolates were recovered from patients with invasive candidiasis, eight being fluconazole and voriconazole-resistant, and two intermediate only to fluconazole (FLC). All non-susceptible isolates showed a similar pattern of biofilm formation with low biomass and metabolic activity. The A395T mutation in ERG11 was detected exclusively among the azole-resistant isolates. According to the microsatellite analysis, all azole non-susceptible isolates from the adult ICU were clustered together indicating the occurrence of an outbreak. Regarding clinical data, all patients infected by the clonal non-susceptible isolates and none of the patients infected by the susceptible isolates had been previously exposed to corticosteroids (p = 0.001), while the remaining characteristics showed no statistical significance. The current study revealed the persistence of an azole non-susceptible C. parapsilosis clone with low capacity to form biofilm over two years in the adult ICU. These results reinforce the need of epidemiological surveillance and monitoring antifungal susceptibility of C. parapsilosis isolates in hospital wards.

1 April 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
MFMaristela p freire
Maristela p freire
DGD. de Oliveira Garcia
D. de Oliveira Garcia
CGC.P. Garcia
C.P. Garcia
MBM.F. Campagnari Bueno
M.F. Campagnari Bueno
Carlos Henrique CamargoCarlos Henrique Camargo
Carlos Henrique Camargo
EAEdson Abdala
Edson Abdala

30 March 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Danilo Yamamoto ThomazDanilo Yamamoto Thomaz
Danilo Yamamoto Thomaz
JJJoão Nobrega De Almeida Júnior
João Nobrega De Almeida Júnior
OSODELI NICOLE ENCINAS SEJAS
ODELI NICOLE ENCINAS SEJAS
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
GCGabrielle O. M. H. Carvalho
Gabrielle O. M. H. Carvalho
GBGil Benard
Gil Benard
Clonal outbreaks due to azole-resistant Candida parapsilosis (ARCP) isolates have been reported in numerous studies, but the environmental niche of such isolates has yet to be defined. Herein, we aimed to identify the environmental niche of ARCP isolates causing unremitting clonal outbreaks in an adult ICU from a Brazilian cancer referral center. C. parapsilosis sensu stricto isolates recovered from blood cultures, pericatheter skins, healthcare workers (HCW), and nosocomial surfaces were genotyped by multilocus microsatellite typing (MLMT). Antifungal susceptibility testing was performed by the EUCAST (European Committee for Antimicrobial Susceptibility Testing) broth microdilution reference method and ERG11 was sequenced to determine the azole resistance mechanism. Approximately 68% of isolates were fluconazole-resistant (76/112), including pericatheter skins (3/3, 100%), blood cultures (63/70, 90%), nosocomial surfaces (6/11, 54.5%), and HCW’s hands (4/28, 14.2%). MLMT revealed five clusters: the major cluster contained 88.2% of ARCP isolates (67/76) collected from blood (57/70), bed (2/2), pericatheter skin (2/3), from carts (3/7), and HCW’s hands (3/27). ARCP isolates were associated with a higher 30 day crude mortality rate (63.8%) than non-ARCP ones (20%, p = 0.008), and resisted two environmental decontamination attempts using quaternary ammonium. This study for the first time identified ARCP isolates harboring the Erg11-Y132F mutation from nosocomial surfaces and HCW’s hands, which were genetically identical to ARCP blood isolates. Therefore, it is likely that persisting clonal outbreak due to ARCP isolates was fueled by environmental sources. The resistance of Y132F ARCP isolates to disinfectants, and their potential association with a high mortality rate, warrant vigilant source control using effective environmental decontamination.

19 September 2018 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
EOE. L. Ori
E. L. Ori
ETE. H. Takagi
E. H. Takagi
TATânia Sueli Andrade
Tânia Sueli Andrade
BMB. T. Miguel
B. T. Miguel
MCM. C. Cergole-Novella
M. C. Cergole-Novella
LSLuis Fernando Dos Santos
Luis Fernando Dos Santos
DiarrhoeagenicEscherichia coli(DEC) is a leading cause of infectious diarrhoea worldwide. In recent years,Escherichia albertiihas also been implicated as a cause of human enteric diseases. This study describes the occurrence ofE. colipathotypes and serotypes associated with enteric illness and haemolytic uremic syndrome (HUS) isolated in Brazil from 2011 to 2016. Pathotypes isolated included enteropathogenicE. coli(EPEC), enteroaggregativeE. coli(EAEC), enterotoxigenicE. coli(ETEC), enteroinvasiveE. coli(EIEC) and Shiga toxin-producingE. coli(STEC). PCR of stool enrichments for DEC pathotypes was employed, andE. albertiiwas also sought. O:H serotyping was performed on all DEC isolates. A total of 683 DEC and 10E. albertiistrains were isolated from 5047 clinical samples. The frequencies of DEC pathotypes were 52.6% (359/683) for EPEC, 32.5% for EAEC, 6.3% for ETEC, 4.4% for EIEC and 4.2% for STEC. DEC strains occurred in patients from 3 months to 96 years old, but EPEC, EAEC and STEC were most prevalent among children. Both typical and atypical isolates of EPEC and EAEC were recovered and presented great serotype heterogeneity. HUS cases were only associated with STEC serotype O157:H7. TwoE. albertiiisolates belonged to serogroup O113 and one had thestx2f gene. The higher prevalence of atypical EPEC in relation to EAEC in community-acquired diarrhoea in Brazil suggests a shift in the trend of DEC pathotypes circulation as previously EAEC predominated. This is the first report ofE. albertiiisolation from active surveillance. These results highlight the need of continuing DEC andE. albertiisurveillance, as a mean to detect changes in the pattern of pathotypes and serotypes circulation and provide useful information for intervention and control strategies.

1 April 2017 in Transplantation
Verified
Journal Article
Closed access
MFMaristela p freire
Maristela p freire
IOIsabel C. V. S. Msc Oshiro
Isabel C. V. S. Msc Oshiro
LPLigia C. Pierrotti
Ligia C. Pierrotti
PBPatricia R. Bonazzi
Patricia R. Bonazzi
LOLarissa M. de Oliveira
Larissa M. de Oliveira
EAEdson Abdala
Edson Abdala
Background Carbapenem-resistant Enterobacteriaceae (CRE) is an emergent microorganism of infections after liver transplant (LT). The aim of this study was to analyze the risk factors for CRE acquisition and infection after LT. Methods This was a prospective cohort study involving patients who underwent LT in the 2010 to 2014 period. Surveillance cultures for CRE were collected immediately before LT and weekly thereafter until hospital discharge. Results We analyzed 386 patients undergoing a total of 407 LTs. Before LT, 68 (17.6%) patients tested positive for CRE, 11 (16.2%) of those patients having CRE infection, whereas 119 (30.8%) patients acquired CRE after LT. Post-LT CRE infection was identified in 59 (15.7%) patients: Klebsiella pneumoniae was isolated in 83.2%; surgical site infection was the most common type of infection (46.7%). Multivariate analysis showed that post-LT dialysis was the only risk factor for post-LT CRE acquisition. Eighty-two percent of patients who underwent 3 or more post-LT dialysis sessions and acquired CRE before LT evolved with post-LT CRE infection. Other risk factors for CRE infection were acquisition of CRE post-LT, Model for End-Stage Liver Disease score greater than 32, combined transplantation, and reoperation. Patients who acquired CRE before LT had a high risk of developing CRE infection (P < 0.001). Conclusions Measures for minimizing that risk, including altering the antibiotic prophylaxis, should be investigated and implemented.